Food dye, TrumpRx, gender affirming care: Morning Rounds

2 2 minutes read

Stay informed about the latest developments in health and medicine by subscribing to STAT’s free newsletter Morning Rounds. Sign up here.

As I sit down to write this article on a Thursday afternoon, Sarah Todd’s captivating story on the connections between Big Tobacco and Big Food has truly caught my attention. Read on to discover more.

TrumpRx Launches

President Trump’s much-anticipated platform aimed at reducing prescription drug prices, known as TrumpRx, was officially launched yesterday amidst much anticipation. The platform, powered by healthcare company GoodRx, provides cash prices for certain medications and directs users to other sources for purchase. However, experts caution that buying medications directly may not always be the most cost-effective option in the long run.

For a detailed overview of TrumpRx and its potential impact, check out the full story.

Hospitals Cease Gender-Affirming Care

In recent months, over 40 hospitals and health systems have halted or discontinued gender-affirming care for young transgender individuals, a trend that has accelerated following proposed federal rules that could withhold funding from clinics offering such services. Despite ongoing legal challenges, many clinics have provided hormone therapy and puberty blockers to transgender youth based on recommendations from medical organizations.

Explore the full story on the challenges faced by hospitals providing gender-affirming care.

Caution Advised with Multi-Cancer Tests

During the upcoming Super Bowl, viewers may encounter Hims’ latest commercial featuring Galleri, a multi-cancer early detection test that has not yet received FDA approval. While the test has shown promise, experts warn that false reassurance could result from negative test results. It is crucial to approach these tests with caution and awareness of potential risks.

For more insights on multi-cancer early detection tests, dive into the full article.

Combatting Ultra-Processed Food

Efforts to raise awareness about the harmful effects of ultra-processed food have drawn parallels to strategies used against the tobacco industry. Critics argue that manufacturers of these products have exploited the brain’s reward system, leading to detrimental health consequences. While the food industry denies these claims, the debate continues on the impact of ultra-processed foods on public health.

Discover more about the comparison between Big Tobacco and Big Food in this insightful piece.

Understanding ‘Natural’ Dyes

The FDA recently announced a shift towards allowing companies to transition from artificial to natural food dyes. This change focuses on whether a dye is derived from natural or petroleum-based sources, aiming to provide clearer labeling for consumers. However, the definition of ‘natural’ dyes encompasses a wide range of sources, including fermentation from yeast, algae, and plants bred for color production.

Get a deeper understanding of ‘natural’ dyes and the FDA’s new labeling approach in this informative article.

Challenges to Evidence-Based Policy

Former FDA Commissioner Robert M. Califf raises concerns about the undermining of evidence-based policy within the Department of Health and Human Services. Highlighting the importance of collective wisdom and expertise in healthcare decision-making, Califf emphasizes the need to prioritize evidence and expertise in shaping public health interventions.

Explore Califf’s insights on evidence-based policy and its significance in healthcare.